Resistin and omentin in breast cancer: A systematic review and meta-analysis
Open Access
- 6 July 2024
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 562, 119838
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Comparison of serum HER-2NEU with histological expression of estrogen receptor in women with metastatic breast cancerClinica Chimica Acta, 2024
- The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responsesCell Biochemistry and Biophysics, 2023
- The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancerClinica Chimica Acta, 2021
- Mendelian randomisation analysis of circulating adipokines and C‐reactive protein on breast cancer riskInternational Journal of Cancer, 2020
- The emerging roles of extracellular vesicles in diabetes and diabetic complicationsClinica Chimica Acta, 2019
- Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancerObesity Research & Clinical Practice, 2016
- Circulating levels of adipocytokine omentin-1 in patients with renal cell cancerCytokine, 2016
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002